Skip to content
healthcare.dev
Get a free key

JYNNEOS

NDC 50632-024, Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen, injection, powder, lyophilized, for suspension, from Bavarian Nordic A/S.

Product NDC
50632-024
Status
Listed
Labeler
Bavarian Nordic A/S
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
SUBCUTANEOUS
Product type
VACCINE
Marketing category
BLA
Application
BLA125678
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50632-024 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN50000000 1/.5mL
Package NDCNDC-11Package
50632-024-025063200240220 VIAL in 1 CARTON (50632-024-02) / .5 mL in 1 VIAL (50632-024-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50632-024 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50632-024 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50632-024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.